• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Psychotropic medications reduce further violent crimes in released prisoners

byDaniel FisherandMichael Milligan
November 4, 2016
in Chronic Disease, Psychiatry, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this cohort study, released prisoners in Sweden who received antipsychotics, psychostimulants, and medications used in addictive disorders were less likely to commit a violent crime.

2. The rates of violent crimes were similar between patients who received psychotropic medications and those who were administered prison-based psychological treatments.

Evidence Rating Level: 2 (Good)

Study Rundown: With more than one third of released prisoners in the US and UK committing violent crimes, there remains a significant need for reducing these rates. As mental illness is overrepresented in prison populations, understanding how psychotropic medications may affect re-offense rates in released prisoners is essential. In this prospective cohort study, released prisoners from Sweeden who did and did not receive psychotropic medications were followed closely with rates of violent crimes recorded. For those who took antipsychotics, psychostimulants, or medications used to treat addictive disorders, the rate of violent crimes was reduced. However, those who received antidepressants or anti-epileptics did not show decreased violent crime rates. Similar results were found for those who were treated before and after release. In comparison, those who received psychological treatments showed similar reductions in violent crime rates.

As randomized controlled trials with violent crimes as an endpoint are hard to design and execute, the evidence in this study is very informative for those deciding on policies to reduce the rates of violent crimes after incarceration. However, the Swedish justice and prison system has many differences from other justice systems, especially those in the US, and so the generalizability of these results is hard to determine.

Click to read the study in JAMA

Relevant Reading: Antipsychotics, mood stabilisers, and risk of violent crime

RELATED REPORTS

Emraclidine is safe and well-tolerated for the treatment of schizophrenia

Variation in antipsychotic medication responsiveness present amongst schizophrenia patients

Prenatal exposure to antipsychotic medications not associated with increased risk of neurodevelopmental disorders in offspring

In-Depth [cohort study]: A total of 22,275 prisoners released from Swedish prisons between 2005 and 2010 were tracked for a median of 4.6 years after release. Among all included in the study, 9915 received psychotropic medications and 5561 completed psychological programs. During follow-up, 4031 (18.1%) people were reconvicted for 5653 violent crimes. The between-individual analyses showed a reduction in violent crimes for prisoners who received antipsychotics (reduction of 21.7 violent crimes per 1000 person years; 95%CI 3.7 to 35.9). Similarly, those taking psychostimulants saw a reduction of 33.9 violent crimes per 1000 person years (95%CI 13.5 to 39.7) and those taking medications for addictive disorders saw a reduction of 27.5 violent crimes per 1000 person years (95%CI 7.0 to 41.6). Those who received antidepressants, antiepileptics, and adrenergic inhalants (negative control) did not show any differences from the un-medicated population. The within-individual analyses showed similar results, with 39.7 (95%CI 11.3 to 57.7) fewer violent offenses in total for antipsychotics, 42.8 for psychostimulants (95%CI2.2 to 67.6), and 36.4 (95%CI 2.1 to 54.0) for medications for addictive disorders. For psychological programs designed to prevent crime generally, the reduction in violent offenses was similar at 11.6 less violent crimes per 1000 person years (95%CI 5.1 to 17.1), and programs designed to treat substance abuse also reduced violent offenses by 23.2 (95%CI 10.3 to 34.1). Surprisingly, programs designed to reduce violent reoffending showed no differences in violent crime offenses.

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: Antipsychoticprison
Previous Post

Antiretroviral therapy lowers mother-to-child HIV transmission rates

Next Post

The LRC-CPPT 1: Cholestyramine and coronary heart disease [Classics Series]

RelatedReports

Majority of pediatric medication-related visits to emergency department are preventable
Chronic Disease

Emraclidine is safe and well-tolerated for the treatment of schizophrenia

December 28, 2022
Majority of pediatric medication-related visits to emergency department are preventable
Psychiatry

Variation in antipsychotic medication responsiveness present amongst schizophrenia patients

September 2, 2022
Publication of pneumonia antibiotic guidelines changed prescribing trends
Obstetrics

Prenatal exposure to antipsychotic medications not associated with increased risk of neurodevelopmental disorders in offspring

March 30, 2022
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Majority of long-acting injectable and oral antipsychotics are similar in efficacy for schizophrenia maintenance therapy

March 15, 2022
Next Post
Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The LRC-CPPT 1: Cholestyramine and coronary heart disease [Classics Series]

Flavored e-cigarette use associated with higher smoking risks in youth

Unmet healthcare need in adolescence linked to poor adult outcomes

Therapy advancements not correlated with improved health status for adult survivors of childhood cancer

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Specific histopathologic renal lesions may be associated with increased risk of cardiovascular disease
  • Symptom and viral relapse more common in COVID-19 patients without antiviral treatment
  • The Scan by 2 Minute Medicine®: Endometriosis Awareness Month, OnlineMedEd Charges, Canadian Grocery Store Controversy, BetterHelp’s Privacy Concerns
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options